Literature DB >> 6541244

Primary central nervous system tumors in stillborns and infants. Epidemiological considerations.

W Jänisch, J F Haas, D Schreiber, H Gerlach.   

Abstract

An epidemiologic investigation of true neoplasms of the central nervous system in fetuses and infants in the German Democratic Republic (GDR) was undertaken. Since all fetal deaths and all deaths in the first year of life are subject to a full postmortem examination and since all cancer cases or deaths are reported to a central registry, the prerequisites for a valid assessment of the incidence of these tumors are present. During the years 1960-1979, 55 histopathologically verified tumors of the central nervous system were identified in the GDR, a frequency of approximately 1.1 per 100 000 births. Unexpectedly, medulloblastoma (13 cases) was the most frequent tumor type.

Entities:  

Mesh:

Year:  1984        PMID: 6541244     DOI: 10.1007/bf00177895

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  2 in total

1.  [Tumors of the central nervous system in children and adolescents].

Authors:  J H Müller; W Jänisch; W Usbeck
Journal:  Dtsch Gesundheitsw       Date:  1971-04-01

2.  [CNS tumors of the perinatal period (author's transl)].

Authors:  H Gerlach; W Jänisch; D Schreiber
Journal:  Zentralbl Allg Pathol       Date:  1982
  2 in total
  14 in total

Review 1.  Long-term survival of an infant with diffuse brainstem lesion diagnosed by prenatal MRI: a case report and review of the literature.

Authors:  M Suo-Palosaari; H Rantala; S Lehtinen; T Kumpulainen; N Salokorpi
Journal:  Childs Nerv Syst       Date:  2016-02-23       Impact factor: 1.475

2.  Congenital primitive neuroectodermal tumour presenting as obstructed labour.

Authors:  D Inwald; S Kempley; M Hird
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-05       Impact factor: 5.747

Review 3.  Posterior fossa tumors in infants and neonates.

Authors:  Pietro Spennato; Giancarlo Nicosia; Lucia Quaglietta; Vittoria Donofrio; Giuseppe Mirone; Giuliana Di Martino; Elia Guadagno; Maria Laura del Basso de Caro; Daniele Cascone; Giuseppe Cinalli
Journal:  Childs Nerv Syst       Date:  2015-09-09       Impact factor: 1.475

4.  Congenital glioblastoma multiforme with abnormal vascularity presenting as intracranial hemorrhage in prenatal ultrasound.

Authors:  Manfred Sell; Sabine Huber-Schumacher; Frank K H van Landeghem
Journal:  Childs Nerv Syst       Date:  2006-05-04       Impact factor: 1.475

5.  Cytogenetic and histopathologic studies of congenital supratentorial primitive neuroectodermal tumors: a case report.

Authors:  H J Girschick; R Klein; W G Scheurlen; J Kühl
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

6.  Intracranial tumours in the first year of life. A report on 51 cases.

Authors:  C Di Rocco; A Ceddia; A Iannelli
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

Review 7.  Treatment of infants with malignant gliomas: the Pediatric Oncology Group experience.

Authors:  P K Duffner; J P Krischer; P C Burger; M E Cohen; J W Backstrom; M E Horowitz; R A Sanford; H S Friedman; L E Kun
Journal:  J Neurooncol       Date:  1996 May-Jun       Impact factor: 4.130

8.  The invasiveness of five medulloblastoma cell lines in collagen gels.

Authors:  Adrianna Ranger; Warren McDonald; Emi Moore; Rolando Delmaestro
Journal:  J Neurooncol       Date:  2009-07-15       Impact factor: 4.130

9.  A case of definitely congenital glioblastoma manifested by intratumoral hemorrhage.

Authors:  Norihito Shimamura; Ken-Ichiroh Asano; Kazumi Ogane; Akinori Yagihashi; Hiroki Ohkuma; Shigeharu Suzuki
Journal:  Childs Nerv Syst       Date:  2003-09-13       Impact factor: 1.475

10.  Prenatal diagnosis of a giant congenital primary cerebral hemangiopericytoma.

Authors:  Gábor Sobel; Judit Halász; Katalin Bogdányi; István Szabó; Katalin Borka; Péter Molnár; Zsuzsa Schaff; Ferenc Paulin; Ferenc Bánhidy
Journal:  Pathol Oncol Res       Date:  2006-03-23       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.